The global artificial intelligence (AI) in cardiology market was valued at USD 1.7 billion in 2025 and is expected to reach USD 2.2 billion in 2026. The market is projected to expand significantly to USD 14.8 billion by 2033, registering a 31.2% CAGR from 2026 to 2033.

North America accounted for the largest revenue share at 46.8% in 2025, supported by advanced healthcare infrastructure, strong adoption of AI-enabled diagnostic technologies, and increasing investments in cardiovascular care. Meanwhile, Asia Pacific is expected to record the fastest growth during 2026–2033.

The expansion of AI in cardiology is being driven by the growing global burden of cardiovascular diseases (CVDs), increasing diagnostic workloads, demand for faster and more precise clinical decision-making, and rapid advances in cardiac imaging. AI technologies are increasingly being applied to electrocardiograms (ECGs), echocardiography, cardiac CT, coronary imaging, and other cardiovascular diagnostic workflows.

What Is Driving the AI in Cardiology Market?

Several structural factors are accelerating the adoption of AI across cardiovascular healthcare:

• Increasing cardiovascular disease prevalence: The growing incidence of heart disease is creating demand for scalable and efficient diagnostic solutions.
• Higher diagnostic workloads: AI can automate portions of ECG, echocardiogram, CT, and other cardiac image and signal analyses, helping clinicians process larger patient volumes.
• Improving diagnostic precision: Machine learning and deep learning can identify patterns that support earlier detection and risk assessment.
• Advances in cardiac imaging: Improvements in medical imaging are creating larger datasets that can be analyzed using AI-based tools.
• Expanding regulatory approvals: The growing number of approved AI-enabled cardiovascular technologies is supporting broader clinical adoption.
• Cloud and data infrastructure development: Cloud computing and big-data analytics are enabling AI platforms to process and integrate large volumes of cardiovascular information.

Download a free sample report or claim your copy of this full market intelligence report

Market Segmentation: Where Is AI Being Used Most?

Diagnosis is the leading application segment, accounting for 40.0% of market revenue in 2025. AI-based diagnostic solutions include automated ECG interpretation, echocardiographic analysis, cardiac CT evaluation, and other tools designed to support the detection and assessment of cardiovascular abnormalities.

By medical condition, ischemic heart disease and coronary artery disease (CAD) represented the largest segment, with a 38.2% share in 2025. AI algorithms are increasingly being developed to support coronary plaque analysis, cardiovascular risk assessment, and identification of clinically relevant disease patterns.

The market is also characterized by strong demand for AI-enabled software, cloud platforms, and data services. However, based on the reported component segmentation, hardware held the largest revenue share of 36.9% in 2025.

Regional Performance

North America remains the leading regional market, capturing 46.8% of global revenue in 2025. The U.S. accounted for the largest share within the region. Strong healthcare infrastructure, technology adoption, research activity, and the availability of advanced cardiovascular diagnostic systems contribute to the region's leadership.

Asia Pacific is projected to be the fastest-growing regional market between 2026 and 2033. Increasing healthcare digitization, rising cardiovascular disease prevalence, expanding access to advanced diagnostic technologies, and growing investments in AI are expected to support market expansion across the region.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Recent Industry Development

AI-enabled cardiovascular imaging is moving beyond research applications toward broader clinical adoption. In January 2026, Cleerly, Inc. announced that Aetna expanded coverage for its AI-QCT plaque analysis technology. The development supports the use of AI-enabled coronary imaging for improved diagnosis and risk assessment of coronary artery disease and could contribute to broader adoption among insured populations.

Innovation is also occurring in cardiac ultrasound and echocardiography. In August 2025, Bordeaux-based AI company DESKi introduced HeartFocus, a cardiac examination software solution integrated with Butterfly Network's handheld ultrasound devices. The technology is available as an application and software development kit and had received FDA clearance in April. It is designed to help healthcare professionals capture complete echocardiographic views with limited training.

Competitive Landscape and Market Characteristics

The AI in cardiology market is fragmented, with competition spanning established healthcare technology companies, medical imaging providers, specialized AI developers, and cardiovascular software companies.

The industry demonstrates a high degree of innovation, driven by developments in machine learning, deep learning, cloud computing, big-data analytics, medical imaging, and automated clinical decision-support technologies. Regulatory influence is also high because AI-based medical technologies must meet stringent requirements for clinical use and commercialization.

Regional expansion is another important characteristic of the market, while mergers and acquisitions remain moderate as established healthcare companies increasingly collaborate with or acquire specialized AI technology providers.

Key Companies in AI in Cardiology

Major companies profiled in the AI in cardiology market include:

• GE HealthCare
• HeartFlow, Inc.
• IDOVEN
• CardiAI
• Ultromics Limited
• Arterys Inc. (Tempus AI)
• Ultrasight
• Koninklijke Philips N.V.
• Vista AI
• Siemens Healthineers

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.